All Stories

  1. Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial

    Article • September 2020, European Respiratory Society (ERS)

    Eric S. White

  2. Changes in biomarkers with nintedanib and sildenafil in subjects with IPF in the INSTAGE trial: subgroup analysis by right heart dysfunction (RHD)

    Article • September 2020, European Respiratory Society (ERS)

    Eric S. White

  3. Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil

    Article • September 2019, European Respiratory Society (ERS)

    Eric S. White

  4. Diagnostic biomarkers for interstitial lung disease

    Article • American Review of Respiratory Disease, May 2016, American Thoracic Society

    Eric S. White